Biomerica Enters Into Master Services Agreement With Confidential Life Sciences Company To Develop Proprietary IVD Assays; Engagement Carries Initial Contract Development Target Fee Of Over $1.75M

Benzinga Newsdesk www.benzinga.com Positive 85.1%

Neg 0% Neu 0% Pos 85.1%

Comments

No comments yet. Be the first!